Literature DB >> 8099610

Decreased expression of the memory marker CD26 on both CD4+ and CD8+ T lymphocytes of HIV-infected subjects.

G Vanham1, L Kestens, I De Meester, J Vingerhoets, G Penne, G Vanhoof, S Scharpé, H Heyligen, E Bosmans, J L Ceuppens.   

Abstract

Using a novel anti-CD26 (or anti-dipeptidyl peptidase IV) monoclonal antibody, we showed that the absolute numbers and the proportions of T4 and T8 cells expressing CD26 were significantly lower in HIV-infected persons than in controls. The absolute number of CD26+ T4 cells decreased according to disease progression, whereas the number of CD26+ T8 cells was low throughout all clinical stages. These trends were similar in CD26 dim and bright positive T-cell subsets. In both controls and HIV-positive subjects, the CD26 bright positive T cells were restricted to the CD45RO+ subset and preferentially co-expressed CD25 but largely lacked HLA-DR and CD38. Recall antigen-responsive cells from seronegative individuals were shown to co-express CD26 and CD45RO. The deficient CD26 expression on T8 cells from HIV-infected subjects could be normally upregulated after in vitro stimulation. In contrast to decreased T-cell-bound CD26, the enzymatic activity of plasma CD26/dipeptidyl peptidase IV was unchanged in HIV-infected patients compared with controls. We conclude that HIV infection leads to a deficient in vivo co-expression of CD26 bright and CD45RO on T cells. We speculate that this deficiency might play a part in the decrease of immunological memory during HIV infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8099610

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  20 in total

1.  Successful immunomodulating in AIDS patients with ursodeoxycholic acid--a pilot study.

Authors:  D Kurktschiev; T Temelkova-Kurktschiev; K Horn; K Schentke
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

2.  Multicolor cytoenzymatic evaluation of dipeptidyl peptidase IV (CD26) function in normal and neoplastic human T-lymphocyte populations.

Authors:  P Ruiz; N Zacharievich; M Shenkin
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

3.  Cytokine analysis at the single cell level and lymphoproliferative responses to mycobacterial antigens in HIV-1 patients with successful virologic response to potent antiretrovirals.

Authors:  C Amiel; J P Kusnierz; Y Mouton; G Rook; J Stanford; M Singh; A Capron; G M Bahr
Journal:  J Clin Immunol       Date:  2000-11       Impact factor: 8.317

4.  Human immunodeficiency virus 1 Tat binds to dipeptidyl aminopeptidase IV (CD26): a possible mechanism for Tat's immunosuppressive activity.

Authors:  W G Gutheil; M Subramanyam; G R Flentke; D G Sanford; E Munoz; B T Huber; W W Bachovchin
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

5.  Microarray analysis of HIV resistant female sex workers reveal a gene expression signature pattern reminiscent of a lowered immune activation state.

Authors:  Elijah M Songok; Ma Luo; Ben Liang; Paul Mclaren; Nadine Kaefer; Winnie Apidi; Genevieve Boucher; Joshua Kimani; Charles Wachihi; Rafick Sekaly; Keith Fowke; Blake T Ball; Francis A Plummer
Journal:  PLoS One       Date:  2012-01-26       Impact factor: 3.240

6.  Effects of subcutaneous interleukin-2 therapy on CD4 subsets and in vitro cytokine production in HIV+ subjects.

Authors:  P De Paoli; S Zanussi; C Simonelli; M T Bortolin; M D'Andrea; C Crepaldi; R Talamini; M Comar; M Giacca; U Tirelli
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

7.  Low relative frequencies of CD26(+) CD4(+) cells in long-term nonprogressing human immunodeficiency virus type 1-infected subjects.

Authors:  C Broström; A Sönnerborg; S Lindbäck; H Gaines
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

8.  Expression of ectopeptidases in scleroderma.

Authors:  G Bou-Gharios; J Osman; A Atherton; P Monoghan; R Vancheeswaran; C Black; I Olsen
Journal:  Ann Rheum Dis       Date:  1995-02       Impact factor: 19.103

9.  Loss of CD26 protease activity in recipient mice during hematopoietic stem cell transplantation results in improved transplant efficiency.

Authors:  Eunsun Yoo; Laura A Paganessi; Wasfia A Alikhan; Elizabeth A Paganessi; Frank Hughes; Henry C Fung; Elizabeth Rich; Chu Myong Seong; Kent W Christopherson
Journal:  Transfusion       Date:  2012-08-06       Impact factor: 3.157

10.  Role of CD26/dipeptidyl peptidase IV in human immunodeficiency virus type 1 infection and apoptosis.

Authors:  C Morimoto; C I Lord; C Zhang; J S Duke-Cohan; N L Letvin; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.